Q2 and H1 FY27 earnings call recording now available

Investor Communications View source PDF Explain this filing

ERIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+8.1%Reaction day

₹1100.00

prior close

₹1134.90

announcement price

After-mkt

timing

Nifty Microcap 250market+1.7%+6.4% vs market

Pharmaceuticals peers, median of 173sector+2.0%+6.1% vs sector

On the reaction day the stock moved 6.4 pts more than Nifty Microcap 250 and 6.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.5

10m

+2.2

15m

+1.4

30m

+0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+8.1+1.7+6.4+2.0+6.1

Next day

+6.7pendingpending+2.6+4.1

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Eris Lifesciences has made available the recording of its October 26, 2026 earnings call on the unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The recording is on the company website under Q2 FY27.

Likely market impact

Investors can review management's discussion, but the filing contains no new financial figures, guidance or outlook to assess separately.